LncRNA DUXAP9‐206 contributes to the proliferation and metastasis of NSCLC by binding with Cbl‐b to prevent the degradation of EGFR and thus ensures the activation of EGFR signaling (Figure 7). Here, DUXAP9 is linked to non-small cell lung carcinoma.